Cefpodoxime Proxetil 200mg + PotassiUm ClavUlanate 125mg

Enhanced antibacterial activity

1. Clavulanic Acid improves cefpodoxime activity against both Gram +ve and Gram -ve pathogens

Larger Zone of Inhibition

1. Resulting in early symptamatic relief

Effective against resistant pathogens

1. Impairs the emergence and spread of resistant pathogens

Effective in switch-over therapy

1. Resulting in reduced length of hospital stay

Indicated in :

Acute Bronchitis

Uncomplicated Urinary Tract Infections

Acute Exacerbations of Chronic Bronchitis